Nanomix

Nanomix Provides Accessible Healthcare for All Patients with a Diagnostic System that is Unmatched in Quality, Speed, Economy, and Portability. Today, we are applying this technology to meet the demands of COVID-19 testing. Managing this pandemic requires mass testing. The Nanomix immunoassay complements PCR testing and is critical for detecting the presence of antibodies during and after infection. The Nanomix Point-of-Care system consists of a handheld, battery-powered instrument and a microfluidic test cartridge that utilizes carbon nanotube biosensors to deliver clinical laboratory performance at the point-of-care or in mobile settings. The system runs on whole blood and provides multiple test results from each patient sample. It can be deployed across a range of settings where quality and timely information are needed, including ambulances, emergency departments, pharmacies, homes, and resource-limited areas.